Quite a few investment analysts working at KeyCorp have already produced their estimates for the EPS of Q1 for SHW- which was further published in a 31st January research report. K. Zener, the analyst from KeyCorp has already predicted that the company dealing in specialty chemicals would be posting an EPS of around $4.94 for the current quarter. It has also been forecasted that the EPS of Q3 would be $8.78, with the Q4 earnings at $5.71.
The Quarterly Estimates of SHW
There have been quite a few research analysts that have commented on the stocks of SHW. Wells Fargo & Company have already given the stocks of SHW a rating of overweight which they published in a 19th January research report. Goldman Sachs Group has, on the other hand, reduced the shares of the company from a rating of ‘conviction-buy’ to a rating of ‘buy’ in a 14th October research report.
Credit Suisse also decided to increase the price target of the company from $845 to a sum of $874. They also introduced a rating of outperform- which they mentioned in a 29th January research note. Morgan Stanley also increased the price target of the company from $785 to a price target of $825- which would later be added to a rating of overweight. In the end, Smith Barney Citigroup also decided to increase the price target of the company from $800 to $818 in a 28th October research note.
One of the investment analysts covering the firm has already given it a rating of sell, while five others have issued it with a rating of hold. Sixteen other analysts provided the firm with a rating of buy. Currently, the company enjoys a Buy rating, with a $726.25.
The stocks of SHW traded on Wednesday at $710.54, with a 0.80 quick ratio, and a 1.96 debt-to-equity ratio. The market cap of the firm is $64.53 billion, with a 35.07 PE ratio, and a PEG ratio of 2.65. The moving average price of the company over 50-days is $726.19, while the moving average price of the company over 200 days is $698.22. The year low of SHW is $325.43, with a year high set at $758.
